Bone Morphogenetic Protein-7 Signals Opposing Transforming Growth Factor β in Mesangial Cells
Open Access
- 1 May 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (22), 23200-23206
- https://doi.org/10.1074/jbc.m311998200
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy11Professor Robert Chevalier served as a guest editor for this paper.Kidney International, 2003
- Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathyBiochemical and Biophysical Research Communications, 2003
- Blockade of maitotoxin-induced endothelial cell lysis by glycine and l-alanineAmerican Journal of Physiology-Cell Physiology, 2003
- Signal Transduction by the TGF-β SuperfamilyScience, 2002
- Signal Transductions Induced by Bone Morphogenetic Protein-2 and Transforming Growth Factor-β in Normal Human Osteoblastic CellsJournal of Biological Chemistry, 2002
- Is Smad3 a Major Player in Signal Transduction Pathways Leading to Fibrogenesis?Chest, 2001
- Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient FibroblastsJournal of Biological Chemistry, 2001
- Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneysKidney International, 2000
- Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7).Proceedings of the National Academy of Sciences, 1996
- A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye.Genes & Development, 1995